MedTrace Logo

Comparison of Platelet-rich Plasma and Activated Cytokine-rich Serum Injection Treatments in Patients With Knee Osteoarthritis. (KOA PRP ACS)

NCT07473232 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-03-19

No results posted yet for this study

Summary

The effects of single dose injection of platelet rich plasma or conditioned serum in the knee joint in patients with knee osteoarthritis will be compared

Conditions

  • Knee Arthritis Osteoarthritis
  • Platelet Rich Plasma Injection
  • Conditioned Serum

Interventions

DRUG

Autologous Platelet-Rich Plasma (PRP)

Autologous Platelet-Rich Plasma (PRP) will be injected intra-articularly in patients with knee osteoarthritis

DRUG

Conditioned serum (CS)

Autologous conditionedserum (CS) will be injected intra-articularly in patients with knee osteoarthritis

Sponsors & Collaborators

  • Pamukkale University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-01
Primary Completion
2026-06-30
Completion
2026-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07473232 on ClinicalTrials.gov